- Home
- EVN vs CRMD Comparison
EVN vs CRMD Comparison
Compare EVN & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVN
- CRMD
- Stock Information
- Founded
- EVN 1998
- CRMD 2006
- Country
- EVN United States
- CRMD United States
- Employees
- EVN N/A
- CRMD N/A
- Industry
- EVN Investment Bankers/Brokers/Service
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- EVN Finance
- CRMD Health Care
- Exchange
- EVN Nasdaq
- CRMD Nasdaq
- Market Cap
- EVN 410.0M
- CRMD 464.7M
- IPO Year
- EVN N/A
- CRMD 2010
- Fundamental
- Price
- EVN $10.44
- CRMD $11.63
- Analyst Decision
- EVN
- CRMD Strong Buy
- Analyst Count
- EVN 0
- CRMD 6
- Target Price
- EVN N/A
- CRMD $15.00
- AVG Volume (30 Days)
- EVN 101.2K
- CRMD 2.3M
- Earning Date
- EVN 01-01-0001
- CRMD 05-06-2025
- Dividend Yield
- EVN 4.78%
- CRMD N/A
- EPS Growth
- EVN N/A
- CRMD N/A
- EPS
- EVN 0.34
- CRMD 0.28
- Revenue
- EVN N/A
- CRMD $82,553,827.00
- Revenue This Year
- EVN N/A
- CRMD $207.65
- Revenue Next Year
- EVN N/A
- CRMD $50.13
- P/E Ratio
- EVN $29.94
- CRMD $41.90
- Revenue Growth
- EVN N/A
- CRMD N/A
- 52 Week Low
- EVN $8.64
- CRMD $3.61
- 52 Week High
- EVN $10.45
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- EVN 62.71
- CRMD 69.76
- Support Level
- EVN $10.32
- CRMD $11.21
- Resistance Level
- EVN $10.53
- CRMD $12.31
- Average True Range (ATR)
- EVN 0.12
- CRMD 0.67
- MACD
- EVN 0.05
- CRMD 0.32
- Stochastic Oscillator
- EVN 83.93
- CRMD 82.29
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.